Synergistic effect of β-cryptoxanthin and zinc sulfate on the bone component in rat femoral tissues in Vitro: The unique anabolic effect with zinc

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 11, 2005, Pages 2142-2145

  Uchiyama, Satoshi ^a   Ishiyama, Kaori ^b   Hashimoto, Ken ^b   Yamaguchi, Masayoshi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Yamada Apiculture Center Inc   (Japan)

Author keywords

cryptoxanthin; Bone formation; Rat femur; Zinc

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ALKALINE PHOSPHATASE; BETA CRYPTOXANTHIN; CALCIUM; CYCLOHEXIMIDE; DNA; GENISTEIN; MENAQUINONE; ZINC; ZINC SULFATE;

ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BONE TISSUE; CALCIUM BONE LEVEL; CONTROLLED STUDY; CULTURE MEDIUM; DIAPHYSIS; DNA CONTENT; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; FEMUR; MALE; METAPHYSIS; NONHUMAN; OSSIFICATION; RAT; TISSUE CULTURE;

ALKALINE PHOSPHATASE; ANABOLIC AGENTS; ANIMALS; BETA CAROTENE; BONE AND BONES; CALCIUM; CYCLOHEXIMIDE; DNA; DRUG SYNERGISM; FEMUR; MALE; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; TISSUE CULTURE TECHNIQUES; XANTHOPHYLLS; ZINC SULFATE;

EID: 27744480791     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.28.2142     Document Type: Article

References (35)

1. Schapira C., Slinn S., Sarid M., Mokadai S., Kabala A., Silbermann M., Bone, 16, 575-582 (1995).
2. Wild R. A., Buchamain J. R., Meyers C., Demers L. M., Proc. Soc. Exp. Biol. Med., 186, 335-360 (1987).
3. Cooper C., Melton J., III, Trends Endocrinol. Metab., 3, 224-229 (1992).
4. Bonjour J.-P., Schurch M.-A., Rizzori R., Bone, 18, 1395-1445 (1996).
5. Muhlbauer R. C., Li F., Nature (London), 401, 343-344 (1999).
6. Yamaguchi M., Uchiyama S., Biol. Pharm. Bull., 26, 1188-1191 (2003)
7. Yamaguchi M., Uchiyama S., Mol. Cell. Biochem., 258, 137-144 (2004).
8. Uchiyama S., Yamaguchi M., Int. J. Mol. Med., 15, 675-681 (2005).
9. Uchiyama S., Yamaguchi M., J. Cell. Biochem., 95, 1224-1234 (2005).
10. Uchiyama S., Yamaguchi M., Biochem. Pharmacol., 67, 1297-1305 (2004).
11. Uchiyama S., Sumida T., Yamaguchi M., Biol. Pharm. Bull., 27, 232-235 (2004).
12. Uchiyama S., Sumida T., Yamaguchi M., J. Health Sci., 50, 491-496 (2004).
13. Uchiyama S., Yamaguchi M., Biol. Pharm. Bull., 28, 1766-1769 (2005).
14. Hashizume M., Yamaguchi M., Mol. Cell. Biochem., 122, 59-64 (1993).
15. Yamaguchi M., Hashizume M., Mol. Cell. Biochem., 136, 163-169 (1994).
16. Yamaguchi M., Segawa Y., Shimokawa N., Tsuzuike N., Tagashira E., Pharmacology, 45, 292-300 (1992).
17. Kishi S., Yamaguchi M., Biochem. Pharmacol., 48, 1225-1230 (1994).
18. Yamaguchi M., J. Trace Elem. Exp. Med., 11, 119-135 (1998).
19. Kishi S., Segawa Y., Yamaguchi M., Biol. Pharm. Bull., 17, 862-865 (1994).
20. Yamaguchi M., Kishi S., Jpn. J. Pharmacol., 63, 203-207 (1993).
21. Yamaguchi M., Uchiyama S., Int. J. Mol. Med., 12, 755-761 (2003).
22. Yamaguchi M., Oishi H., Suketa Y., Biochem. Pharmacol., 36, 4007-4012 (1987).
23. Walter K., Schutt C., "Methods of Enzymatic Analysis," ed. by Bergmeyer H. U., Academic Press, New York, 1965, pp. 856-860.
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-273 (1951).
25. Flanagan B., Nichols G. J., J. Biol. Chem., 237, 3686-3692 (1962).
26. Ceriotti G., J. Biol. Chem., 214, 39-77 (1955).
27. Yamaguchi M., Inamoto K., Suketa Y., Res. Exp. Med., 186, 337-342 (1986).
28. Gao Y. H., Yamaguchi M., Biochem. Pharmacol., 58, 767-772 (1999).
29. Yamaguchi M., Sugimoto E., Hachiya S., Mol. Cell. Biochem., 223, 131-137 (2001).
30. Sugimoto E., Yamaguchi M., Int. J. Mol. Med., 5, 515-520 (2000).
31. Yamaguchi M., Sugimoto E., Hachiya S., Mol. Cell. Biochem., 223, 131-137 (2001).
32. Majeska R. J., Wuthier R. E., Biochim. Biophys. Acta, 391, 51-60 (1975)
33. Canalis E., Centrella M., Bunch W., McCarthy T. L., J. Clin. Invest., 83, 60-65 (1989).
34. Yamaguchi M., Oishi H., Suketa Y., Biochem. Pharmacol., 37, 4075-4080 (1988).
35. Yamaguchi M., Kishi S., Hashizume M., Peptides, 15, 1367-1371 (1994).